Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Neurocrine Biosciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
NBIX
Nasdaq
2836
https://www.neurocrine.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Neurocrine Biosciences, Inc.
Sentia Medical Sciences and Neurocrine Biosciences Extend Research Collaboration to Discover Novel CRF Peptides
- Apr 16th, 2024 8:01 pm
Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2024 Financial Results
- Apr 10th, 2024 8:01 pm
11 Best Biotech ETFs To Buy
- Apr 9th, 2024 11:37 am
Is Neurocrine Biosciences, Inc.'s (NASDAQ:NBIX) Recent Performance Tethered To Its Attractive Financial Prospects?
- Apr 3rd, 2024 2:36 pm
Neurocrine Biosciences Announces First-Patient Dosed in Phase 2 Clinical Study Evaluating NBI-1070770 in Adults with Major Depressive Disorder
- Apr 3rd, 2024 12:30 pm
Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1065890, a Second-Generation VMAT2 Inhibitor, in Healthy Adults
- Mar 28th, 2024 12:30 pm
S&P 500 Giants Lead Five Stocks Near Buy Points With Fed's Powell A Tailwind
- Mar 23rd, 2024 12:00 pm
Dow Jones Futures: Apple Sour, But These 11 Stocks Flash Buy Signals; FedEx Soars
- Mar 22nd, 2024 11:25 am
AI Plays HubSpot, Arista Networks Lead Five Stocks Near Buy Points In Classic Base
- Mar 16th, 2024 12:00 pm
Neurocrine Biosciences Inc's Chief Regulatory Officer Ingrid Delaet Sells 3,000 Shares
- Mar 16th, 2024 5:23 am
Director Richard Pops Sells 23,200 Shares of Neurocrine Biosciences Inc (NBIX)
- Mar 16th, 2024 5:23 am
Neurocrine Biosciences Is Pioneering Therapies for Neurological Disorders
- Mar 15th, 2024 2:00 pm
Director Richard Pops Sells Shares of Neurocrine Biosciences Inc (NBIX)
- Mar 13th, 2024 5:26 am
Neurocrine Biosciences to Participate at Virtual Investor Conferences in March
- Mar 11th, 2024 8:01 pm
The $1 Billion Opportunity Driving IBD Stock Of The Day Neurocrine Higher
- Mar 11th, 2024 5:12 pm
3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success
- Mar 6th, 2024 9:45 pm
Neurocrine Biosciences Inc's Chief Regulatory Officer Ingrid Delaet Sells Company Shares
- Mar 1st, 2024 5:40 am
Neurocrine Biosciences to Participate at Investor Conferences in March
- Feb 27th, 2024 9:01 pm
Director Richard Pops Sells 15,000 Shares of Neurocrine Biosciences Inc
- Feb 23rd, 2024 4:28 am
11 Best Small-Cap Growth Stocks to Invest In
- Feb 22nd, 2024 8:55 am
Scroll